Cargando…
Safety and efficacy outcomes of 3rd generation DES in an all‐comer population of patients undergoing PCI: 12‐month and 24‐month results of the e‐Biomatrix French registry
OBJECTIVES: The French Ebiomatrix registry aimed to confirm the results of the Leaders trial in an all‐comer population in France. BACKGROUND: The Leaders trial showed the Biolimus‐eluting‐sent (BES) to be equivalent to the Cypher stent in terms of safety and efficacy at 1 year and superior regardin...
Autores principales: | Maupas, Eric, Lipiecki, Janusz, Levy, Raphy, Faurie, Benjamin, Karsenty, Bernard, Moulichon, Marc Eric, Brunelle, François, Maillard, Luc, de Poli, Fabien, Lefèvre, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724651/ https://www.ncbi.nlm.nih.gov/pubmed/28544186 http://dx.doi.org/10.1002/ccd.27081 |
Ejemplares similares
-
A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP—AMI)
por: Victor, Suma M, et al.
Publicado: (2014) -
The future of angiography: Estimates of FFR pre‐ and post‐PCI
por: Tehrani, David M., et al.
Publicado: (2022) -
Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
por: Buiten, Rosaly A., et al.
Publicado: (2020) -
The Single‐access for Hi‐risk PCI (SHiP) technique
por: Wollmuth, Jason, et al.
Publicado: (2019) -
Effect of prehospital treatment in STEMI patients undergoing primary PCI
por: Fabris, Enrico, et al.
Publicado: (2022)